Niti Aayog meets Top pharma execs to find ways to mitigate coronavirus impact; DoP seeks export ban on 12 APIs Medical Dialogues Bureau21 Feb 2020 11:58 AM ISTThe meeting was attended by Biocon's Kiran Mazumdar Shaw, Zydus' Pankaj Patel and Dr Reddy's Laboratories' Satish Reddy and other top pharma execs
FDI in drugs and pharma sector rose to Rs 2065 crore in April-Sept FY20: Government Farhat Nasim9 Feb 2020 11:00 AM IST The foreign direct investment (FDI) equity inflow in the drugs and pharmaceutical sector stood at Rs 1,842 crore in FY 2018-19, Minister of State...
Former BDM, others arrested for stealing data from pharma firm Farhat Nasim15 Jan 2020 10:30 AM ISTInvestigations revealed that the prime accused, who was a Business Development Manager in the pharma company was fired on the charge of malpractices.
Alembic Pharma gets USFDA nod for spasticity drug Tizanidine MD bureau15 Jan 2020 10:15 AM ISTNew Delhi: Drug firm Alembic Pharmaceuticals on Wednesday said it has received final nod from the US health regulator for Tizanidine hydrochloride...
SEBI exempts Trust from making open offers for Torrent Group Companies MD bureau15 Jan 2020 10:00 AM IST The trust currently does not hold any shares in these three firms. Pursuant to the scheme of amalgamation, the trust will hold over 71.2 per cent...
DoP rejects Geltec plea to review price of Ibuprofen Capsule fixed by NPPA Farhat Nasim13 Jan 2020 3:44 PM ISTNew Delhi: In a major setback to drugmaker Geltec Private Limited, the Department of Pharmaceuticals (DoP) has junked its review petition against the...
MSD India appoints Rehan A Khan as Managing Director Medical Dialogues Bureau10 Jan 2020 12:04 PM ISTRehan A Khan was also a board member and advisor to several impacts led Private Equity funds and to healthcare companies in Africa, India, and...
More drugmakers including Gilead, Biogen, BMS to hike US prices for 50 drugs Medical Dialogues Bureau2 Jan 2020 2:48 PM ISTNew Delhi: Drugmakers including Bristol-Myers Squibb Co (BMY.N), Gilead Sciences Inc (GILD.O), and Biogen Inc (BIIB.O) hiked U.S. list prices on more...
FIRST: Mylan, Micro Labs get USFDA nod for generic version of blood thinner Eliquis Medical Dialogues Bureau24 Dec 2019 9:45 AM ISTSales of Eliquis, which Bristol-Myers co-developed with Pfizer, rose 22% to $1.93 billion and made up about 30% of the Bristol-Myers' total revenues...
Zydus Cadila unveils affordable anti-diabetic drug Vildagliptin under brands Vinglyn, Vinglyn M Medical Dialogues Bureau12 Dec 2019 11:53 AM ISTAhmedabad: With the Novartis Blockbuster Vildagliptin going off patent, Zydus Cadila has taken made its move towards affordable diabetes care in India...
Omega Healthcare appoints Sumit Sachdeva as Chief Growth Officer to expand pharma segment Medical Dialogues Bureau28 Nov 2019 9:10 AM ISTSumit Sachdeva brings over 20 years of experience in the Healthcare Services industry having held global positions strategizing and driving growth...
Pfizer Abrilada, biosimilar to Humira gets USFDA nod for multiple inflammatory conditions Farhat Nasim20 Nov 2019 12:44 PM ISTNew Delhi: Pfizer Inc. recently announced the United States (U.S.) Food and Drug Administration (USFDA) has approved ABRILADA (adalimumab-afzb), as a...
